The medical devices behind endometrial ablation are reshaping menstrual health. From thermocouples to transmitting wires, how ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Ablation of the posterior nasal nerve leads to durable reductions in symptoms of chronic rhinitis, new research shows.

Imricor receives CE Mark certification for the Advantage-MR system under new European Medical Device Regulation as it hits ...

The NeuroOne OneRF Ablation System is a new device with FDA-cleared technology designed for both diagnosing and treating ...

Despite promising technology and FDA clearances, Pulse Biosciences lacks a revenue stream and remains in the testing phase ...

Jackson-Madison County General Hospital now offers a new therapy to treat patients with advanced atrial fibrillation, who ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

The US Ablation Technology Market is projected to reach US$3.87 billion by 2030 from US$2.44 billion in 2025, at a CAGR of ...

The global cryoballoon ablation system market is on an impressive growth trajectory, with recent forecasts projecting its value to reach USD 1.8 billion by 2033, up from an estimated USD 1.1 billion ...